Fluoroquinolones and Aortic Disorders Webinar
About the Webinar:
Fluoroquinolone antibiotics (FLQs), including Cipro® and Levaquin®, have been linked to increased incidents of aortic aneurysms and dissections. On December 20, 2018 the FDA updated the safety announcement to recognize the risk of aortic disorders, expanding on the previously recognized risks for permanent damage to tendons, joints, nerves, and central nervous system. Hear from John Restaino, John Dalimonte, and Kim Loutey for a rapid response discussion on the science, important studies, future litigation, and case selection considerations.
$179 for AAJ Members
$65 for additional AAJ Members using the same computer
Contact AAJ Education: 800-622-1791 | 202-965-3500, ext. 8612 | firstname.lastname@example.org
Fluoroquinolone Antibiotics (FLQs): Drug Information and Overview
- Overview of the Drug
- Previous FDA Warnings – Risk of Tendinitis, Tendon Rupture, Nerve Damage, etc.
- Mechanisms of Action
Understanding the Science Behind the Risk of Aortic Disorders
- Updated FDA Warning
- Degradation of the Arterial Wall and the Risk of Aortic Dissections/Aneurysm
- Epidemiological Studies
- Overview of Pending FLQ Litigation
- Case Selection and Screening: Aortic Dissections/Aneurysm
- The Generic Drug issue
Charles L. Bennett
College of Pharmacy, University of South Carolina
John A. Dalimonte
Dalimonte Rueb, LLC
Kennerly Loutey, LLC
John M. Restaino
Restaino Law, LLC
This webinar streams online through GoToWebinar software.
Time: 2:00 pm – 3:30 pm Eastern Time
Check-in: 1:55 pm Eastern Time
PLEASE ADJUST FOR YOUR LOCAL TIME
12:55 pm—Central Time
11:55 am—Mountain Time
10:55 am—Pacific Time
Note: Parts of Arizona and Hawaii do not observe daylight savings. Please be sure to note correct time for the webinar you register for.
Confirmation of your registration will be sent via email within one day of registration. Access instructions, course materials, and CLE information for this webinar will be sent to you via email one day before the program.
Recordings of this webinar are available for purchase through our audio/video provider Playback Now. Please call 800.241.7785 or click HERE to place your order. Fulfillment of orders will occur one week after the program date.
This webinar is currently in the process of being credited for 1.3 hours of CLE credit.
Please Note: Contact your state CLE administrator to determine whether it accepts webinars for mandatory CLE credit. Earn approximately 1.5* CLE credits to be applied to your participation in AAJ’s professional recognition programs. AAJ Education programs are routinely accredited by states requiring continuing legal education. CLE questions may be addressed by reading our FAQ or by calling the CLE Assistant at 800-622-1791 or 202-965-3500, ext. 8612.
*Number of credits may vary depending on calculation method used by individual state accreditation agencies. AAJ is a State Bar of California MCLE-approved provider.
*The State of Ohio requires providers of Continuing Legal Education to submit programs for approval 60 days in advance of the program’s start date. Although we make every effort to submit programs for approval within the stated guidelines, many programs that we offer are rapid response. As a result we are often unable to comply with the guidelines set forth by the Supreme Court of Ohio. Please contact the AAJ Education Department at 800.622.1791 or 202.965.3500, ext. 8612 to verify whether the program has been approved by Ohio prior to registration. Please Note: Contact your state CLE administrator to determine whether it accepts webinars for mandatory CLE credit.
No refunds or vouchers for cancellations. Your registration fee may be applied towards the purchase of the audio recording upon request, provided the request is made in advance of the webinar.
Please consider a donation to the AAJ Education Fund 501(c)(3). Contributions support educational programs and activities to preserve and protect the civil justice system. Learn more>>
By registering for this AAJ Education program, you agree to receive electronic, written, and telephonic communication from AAJ staff regarding the program and to have your name, firm, city, and state included on the participant and exhibitor/sponsor roster. AAJ may also need to contact you to service your membership record or to provide you with information about your membership, products and services, and advocacy and legislative updates. By providing your contact information, including phone number, fax number, and email address, you consent and give permission for AAJ to contact you by any of those means, which may include calls to your mobile phone, faxes, or emails. You may contact AAJ at any time to change your preferences.